Skip to content
Search

Latest Stories

The King’s Fund responds to Conservative pledges to boost NHS community services

The King’s Fund responds to Conservative pledges to boost NHS community services
PM Rishi Sunak emphasises the importance of investing in community services to secure the NHS’s future

The Conservative Party has pledged to bolster NHS community services, but Sarah Woolnough, Chief Executive of The King’s Fund, expressed caution regarding the announced £1 billion annual funding increase by 2029/2030.

“The funding announced today will only deliver limited changes, and must be just a first step if the government is serious about implementing this much-needed shift to primary and community health services,” Woolnough stated.


Woolnough praised the focus on primary and community care, emphasising its potential to offer quicker, more convenient access for patients and to ease the strain on hospitals by enabling more community-based diagnosis and treatment.

“Bolstering primary and community care services is likely to be welcomed by patients who would like access to care quickly and conveniently, and is also critical to achieving an effective and sustainable health and care system,” she noted.

She added, “This re-focusing can also help diagnose conditions earlier, when treatment is more likely to be successful.”

Despite recent increases in NHS funding to meet the needs of an aging population, Woolnough highlighted the disparity in growth between acute hospital trusts, which have seen a 27 per cent increase since 2016/17, and community trusts, which have only seen a 14 per cent increase.

Woolnough also voiced concerns about funding these initiatives by reducing NHS managerial positions.

“Funding these pledges by making cuts to NHS managers risks sabotaging the goals of the policy.

"Achieving an efficient and productive health service requires experts who can streamline processes, align incentives, and create the environments for clinicians to focus on what they do best – delivering patient care,” she argued.

The Conservatives’ plan includes expanding the Pharmacy First service to treat more conditions, such as menopause, acne, and chest infections, modernising GP surgeries, and constructing 50 new community diagnostic centers (CDCs).

These measures aim to enhance healthcare accessibility and reduce hospital pressures.

Prime Minister Rishi Sunak emphasised the importance of investing in community services to secure the NHS’s future.

“The NHS is one of our most important national assets and the Conservatives are taking the long-term decisions to secure its future,” he stated.

He praised pharmacies for their essential role in communities and announced plans to expand Pharmacy First, which is expected to free up GP appointments and improve care accessibility.

“Pharmacies are the lifeblood of their communities,” Sunak said.

Health Secretary Victoria Atkins echoed Sunak’s sentiments, highlighting the success of Pharmacy First and the new CDCs.

“Pharmacies, GPs, and Community Diagnostic Centres are the backbone of our NHS,” she said.

She stressed the need for ongoing efforts to ensure health services remain accessible locally, aiming to make the NHS faster, simpler, and fairer for all.

Key elements of the expansion plan include offering more treatments through Pharmacy First, building and modernising GP surgeries, and creating additional CDCs to significantly increase diagnostic capacity.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less